from GenomeWeb by Madeleine Johnson
NEW YORK (GenomeWeb) – Researchers at the University of California, San Diego have been awarded funding to develop a panel of extracellular RNA biomarkers for non-invasive glioma brain tumor diagnosis.
The research is being conducted in the lab of Bob Carter, a professor and chief of neurosurgery at UC San Diego Health System and a researcher in UCSD’s Center for Theoretical and Applied Neuro-Oncology.
The two-year grant, totaling $984,048, is the second phase of funding for this research awarded by the National Institutes of Health’s National Center of Advancing Translational Sciences.
In 2013, the NIH Common Fund began providing support for 30 exRNA research projects, and NCATS currently administers 18 of those projects, including Carter’s.
Today, NCATS officially announced the second round of exRNA research funding, noting specific focus areas including Alzheimer’s disease, multiple sclerosis, kidney disease, brain injury, pregnancy complications, heart disease, heart attack, and stroke, as well as liver, stomach, and brain cancers. (read more…)